Terns Pharma

$2.36 0.00% ($0.00)
  • 1D
  • 1W
  • 1M
  • 1Y
  • 5Y
  • YTD

Get ready to invest


About Terns Pharma

Terns Pharmaceuticals, Inc. operates as a biopharmaceutical company. The Company discovers and develops molecularly-targeted and oral molecule drugs for the treatment of liver disease and cancer. Terns Pharmaceuticals serves customers worldwide.

Stock Analysis

last close $2.36
1-mo return 34.9%
3-mo return -13.6%
avg daily vol. 184.75T
52-week high 13.77
52-week low 1.45
market cap. $68M
forward pe -
annual div. -
roe -29.9%
ltg forecast -
dividend yield -
annual rev. $1M
inst own. 92.9%

Subscribe now for daily local and international financial news